サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1231669

イーファーマシーの世界市場

ePharmacies
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
イーファーマシーの世界市場
出版日: 2023年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

イーファーマシーの世界市場は2030年に2,778億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に853億米ドルと推定されるイーファーマシーの世界市場は、2030年までに2778億米ドルの改定規模に達し、2022年から2030年にかけてCAGR 15.9%で成長すると予測しています。本レポートで分析したセグメントの一つであるOver-the-Counter Productsは、CAGR15.3%を記録し、分析期間終了時には3,561億米ドルに達すると予測されます。パンデミック後の回復を考慮し、処方薬セグメントの成長は、今後8年間のCAGRが16.9%に修正されました。

米国市場は250億米ドル、中国はCAGR15.1%で成長予測

米国のイーファーマシー市場は、2022年には250億米ドルに達すると推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが15.1%で、2030年には474億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ13.2％と12.6％の成長が予測されています。欧州では、ドイツがCAGR9.6%で成長すると予測されています。

調査対象企業の例

  • 1mg Technologies Pvt. Ltd.
  • Canada Drugs
  • DocMorris NV
  • Dr Fox Pharmacy
  • eDrugstore.com
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • InternationalDrugMart.com
  • MediSave
  • Netmeds Marketplace Limited
  • OptumRx, Inc.
  • PlanetRx
  • Rowlands Pharmacy
  • The Kroger Company
  • Walgreen Co.,
  • Wal-Mart Stores, Inc.
  • Zur Rose Group AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-6829

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global ePharmacies Market to Reach $277.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for ePharmacies estimated at US$85.3 Billion in the year 2022, is projected to reach a revised size of US$277.8 Billion by 2030, growing at aCAGR of 15.9% over the period 2022-2030. Over-the-Counter Products, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$356.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prescription Medicine segment is readjusted to a revised 16.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $25 Billion, While China is Forecast to Grow at 15.1% CAGR

The ePharmacies market in the U.S. is estimated at US$25 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$47.4 Billion by the year 2030 trailing a CAGR of 15.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.2% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 37 Featured):

  • 1mg Technologies Pvt. Ltd.
  • Canada Drugs
  • DocMorris NV
  • Dr Fox Pharmacy
  • eDrugstore.com
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • InternationalDrugMart.com
  • MediSave
  • Netmeds Marketplace Limited
  • OptumRx, Inc.
  • PlanetRx
  • Rowlands Pharmacy
  • The Kroger Company
  • Walgreen Co.,
  • Wal-Mart Stores, Inc.
  • Zur Rose Group AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • ePharmacy on the Roll Despite Stumbling Blocks
    • Recent Market Activity
    • Inherent Benefits of the Channel - A Key Driving Factor
    • Regulations - A Game Changer for the ePharmacy Market
    • Legal Status of Online Sale of Medications - Prescription and Non-Prescription in Select Markets
    • ePharmacies - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • 1mg Technologies Pvt. Ltd. (India)
    • Canada Drugs (Canada)
    • Dr Fox Pharmacy (UK)
    • eDrugstore.com (USA)
    • Express Scripts Holding Company (USA)
    • Giant Eagle, Inc. (USA)
    • InternationalDrugMart.com (Cyprus)
    • Lloyds Pharmacy Ltd. (UK)
    • MediSave (Canada)
    • Netmeds Marketplace Limited (India)
    • OptumRx, Inc. (USA)
    • PlanetRx (UK)
    • Rowlands Pharmacy (UK)
    • Sanicare-Apotheke (Germany)
    • T.mall.com (China)
    • The Kroger Company (USA)
    • Walgreen Co. (USA)
    • Wal-Mart Stores, Inc. (USA)
    • Yihaodian (China)
    • Zur Rose Group AG (Switzerland)
    • DocMorris NV (Netherlands)
  • 3. MARKET TRENDS & DRIVERS
    • ePharmacies Bring Potential Value to Customers
    • ePharmacies Enable Better Care and Enhance Quality of Life
    • Prescription Drugs Fuel the Growth of Electronic Pharmacies
    • Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
    • Ballooning Elderly Population: The Vital Growth Driver
    • Internet Globalizes Drug Sales through ePharmacies
    • Expanding Internet User Base: A Key Driving Force
    • Rising Smartphone Usage Supports Growing Adoption
    • Re-importation or Cross Border Drug Sales: An Area of Concern in the US
    • Cyber Crime in the Name of ePharmacies on the Rise
    • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
    • Perils of Counterfeit and Fake Drugs
    • Operation Pangea X - A Major Crackdown against Illegal Online Pharmacies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Over-the-Counter Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Prescription Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 10: USA Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 11: USA Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: USA 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 14: Canada Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: Canada 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • JAPAN
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 16: Japan Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 17: Japan Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: Japan 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • CHINA
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 19: China Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: China Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: China 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • EUROPE
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 22: Europe Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: Europe 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 25: Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • FRANCE
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 28: France Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: France Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: France 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • GERMANY
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 31: Germany Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Germany Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Germany 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Italy Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Italy 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 37: UK Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: UK Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: UK 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Rest of Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Rest of Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 43: Asia-Pacific Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Asia-Pacific Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Asia-Pacific 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 46: Rest of World Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Rest of World Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Rest of World 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

IV. COMPETITION